| Paper & Forest Products Industry | Materials Sector | Dr. Alois Waldburg-Zeil CEO | LSE Exchange | CH0001624714 ISIN |
| DE Country | 1,249 Employees | - Last Dividend | - Last Split | - IPO Date |
CPH Chemie + Papier Holding AG operates as a multifaceted entity involved in the development, manufacturing, and distribution of an array of products in the chemicals, paper, and pharmaceutical packaging industries. With its roots going back to 1818, the company has established a significant presence not only in its headquarters in Root, Switzerland but also across diverse global markets including the rest of Europe, the Americas, and Asia. By leveraging its extensive history and expertise, CPH Chemie + Papier Holding AG has positioned itself as a key player in its respective industries, offering innovative products and solutions to meet the varied needs of its clients.
Under the Zeochem brand, this division focuses on the development, manufacture, and distribution of a comprehensive line of molecular sieves, special zeolites, chromatography gels, and deuterated solvents. These products find application across various industries, including pharmaceuticals, and are designed to meet high-quality standards and performance requirements.
Known for its Perlen Papier brand, the Paper division specializes in the production of newsprint and magazine paper. A significant emphasis is placed on sustainability, with a strong commitment to recycling domestically recovered paper to produce its paper products. This division embodies the company’s dedication to environmental responsibility alongside manufacturing excellence.
The Packaging division, operating under the Perlen Packaging brand, offers a diverse portfolio of packaging solutions specifically tailored for the pharmaceutical industry. This includes PVC monofilms and coated PVdC high-barrier films, designed to provide optimal protection for pharmaceutical products. Through innovative research and development, this division ensures that its packaging solutions meet the stringent requirements of the pharmaceutical sector, safeguarding product integrity and extending shelf life.